Table 3.
Cox regression analyses for MACE
| Univariable | Multivariable | |||
|---|---|---|---|---|
| Variables | HR (95% CI) | P value | HR (95% CI) | P value |
| Age | 1.06 (1.05–1.07) | <0.001 | 1.02 (1.01–1.04) | 0.001 |
| Male | 1.10 (0.93–1.31) | 0.277 | 1.24 (1.04–1.49) | 0.017 |
| BMI | 1.00 (0.98–1.03) | 0.918 | 1.00 (0.98–1.03) | 0.989 |
| Ischaemic aetiology | 1.50 (1.27–1.77) | <0.001 | 0.96 (0.80–1.15) | 0.634 |
| Hypertension | 0.98 (0.83–1.16) | 0.801 | 1.04 (0.88–1.24) | 0.625 |
| Diabetes | 0.96 (0.81–1.13) | 0.585 | 0.88 (0.74–1.04) | 0.129 |
| Smoking | 1.09 (0.92–1.28) | 0.329 | 1.02 (0.86–1.21) | 0.790 |
| NYHA class | 1.86 (1.70–2.04) | <0.001 | 1.06 (0.91–1.22) | 0.454 |
| LVEF | 1.08 (1.05–1.11) | <0.001 | 1.06 (1.03–1.09) | <0.001 |
| Log NT‐proBNP | 3.22 (1.83–7.54) | <0.001 | 2.63 (1.47–4.69) | 0.001 |
| eGFR | 1.01 (1.01–1.02) | <0.001 | 1.01 (1.00–1.01) | 0.042 |
| Log RBP4 | 3.26 (1.92–7.27) | <0.001 | 2.61 (1.19–5.70) | 0.016 |
BMI, body mass index; CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LVEF, left ventricular eject fraction; MACE, major adverse cardiac event(s); NT‐proBNP, N terminal pro brain natriuretic peptide; NYHA, New York Heart Association; RBP4, retinol‐binding protein 4.